EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)

Peng Qu, Lanfang Li, Qi Jin, Donghai Liu, Yuan Qiao, Yijia Zhang, Qiuyue Sun, Shuman Ran, Zecheng Li, Tongtong Liu, Liang Peng

International Journal of Molecular Medicine · 2024

DOI: 10.3892/ijmm.2024.5428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2024. Verfasst von Peng Qu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medical Sciences, China‑Japan Friendship Hospital, Beijing 100029, P.R. China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Histones, Epigenesis, Genetic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end‑stage renal disease, and is characterized by persistent proteinuria and decreased glomerular filtration rate. Despite extensive efforts, the increasing incidence highlights the urgent need for more effective treatments. Histone methylation is a crucial epigenetic modification, and its alteration can destabilize chromatin structure, thereby regulating the transcriptional activity of specific genes. Histone methylation serves a substantial role in the onset and progression of various diseases. In patients with DKD, changes in histone methylation are pivotal in mediating the interactions between genetic and environmental factors. Targeting these modifications shows promise in ameliorating renal histological manifestations, tissue fibrosis and proteinuria, and represents a novel therapeutic frontier with the potential to halt DKD progression. The present review focuses on the alterations in histone methylation during the development of DKD, systematically summarizes its impact on various renal parenchymal cells and underscores the potential of targeted histone methylation modifications in improving DKD outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesHistonesEpigenesis, GeneticHumansAnimalsMethylationProtein Processing, Post-TranslationalHistone Code

Stichwörter der Autor:innen

DKDepigeneticshistone methylationinhibitorstranscriptional regulation

Substanzen

Histones

Autor:innen und Institutionen

  • Institute of Clinical Medical Sciences, China‑Japan Friendship Hospital, Beijing 100029, P.R. China.
  • Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100029, P.R. China.
  • China‑Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100029, P.R. China.
  • Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, P.R. China.
  • Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, P.R. China.

Zitieren

APA

Qu, P., Li, L., Jin, Q., Liu, D., Qiao, Y., Zhang, Y., Sun, Q., Ran, S., Li, Z., Liu, T., & Peng, L. (2024). Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2024.5428

Vancouver

Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y, et al. Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). International Journal of Molecular Medicine. 2024. doi:10.3892/ijmm.2024.5428

BibTeX
@article{Qu2024,
  author = {Qu, Peng and Li, Lanfang and Jin, Qi and Liu, Donghai and Qiao, Yuan and Zhang, Yijia and Sun, Qiuyue and Ran, Shuman and Li, Zecheng and Liu, Tongtong and Peng, Liang},
  title = {Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  doi = {10.3892/ijmm.2024.5428}
}
Kostenlos starten →